Free Trial

Short Interest in EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Drops By 91.7%

EssilorLuxottica logo with Medical background

Key Points

  • Short interest in EssilorLuxottica Unsponsored ADR dropped by 91.7%, falling from 1,200 shares to only 100 shares as of September 15th.
  • The stock price of EssilorLuxottica reached $163.00 after trading up by $1.59, with a one-year range spanning from a low of $114.09 to a high of $163.18.
  • Analysts have upgraded EssilorLuxottica from a "strong sell" to a "hold" rating, with one analyst giving a "buy" rating and two assigning a "hold" rating, resulting in an average rating of "hold."
  • Five stocks to consider instead of EssilorLuxottica.

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) was the recipient of a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 100 shares, a decrease of 91.7% from the August 31st total of 1,200 shares. Based on an average trading volume of 110,800 shares, the days-to-cover ratio is presently 0.0 days. Based on an average trading volume of 110,800 shares, the days-to-cover ratio is presently 0.0 days.

EssilorLuxottica Price Performance

ESLOY stock traded up $1.59 on Tuesday, reaching $163.00. The company had a trading volume of 28,290 shares, compared to its average volume of 41,957. EssilorLuxottica has a 1 year low of $114.09 and a 1 year high of $163.18. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.95 and a quick ratio of 0.65. The company's fifty day moving average is $153.57 and its 200 day moving average is $145.71.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Zacks Research upgraded EssilorLuxottica from a "strong sell" rating to a "hold" rating in a research note on Wednesday, September 10th. Barclays assumed coverage on EssilorLuxottica in a report on Tuesday, September 9th. They set an "overweight" rating for the company. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, EssilorLuxottica presently has an average rating of "Hold".

View Our Latest Report on EssilorLuxottica

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EssilorLuxottica Right Now?

Before you consider EssilorLuxottica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.

While EssilorLuxottica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.